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OBJECTIVE: Previous studies have demonstrated a relationship between brain oxidative stress and
cardiovascular regulation. We evaluated the effects of central catalase inhibition on cardiovascular responses
in spontaneously hypertensive rats exposed to sidestream cigarette smoke.
METHODS: Male Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SH) (16 weeks old) were
implanted with a stainless steel guide cannula leading into the fourth cerebral ventricle (4th V). The femoral
artery and vein were cannulated for arterial pressure and heart rate measurement and drug infusion,
respectively. The rats were exposed to sidestream cigarette smoke for 180 minutes/day, 5 days/week for 3 weeks
(CO: 100-300 ppm). The baroreflex was tested using a pressor dose of phenylephrine (8 mg/kg, bolus) and a
depressor dose of sodium nitroprusside (50 mg/kg, bolus). Cardiovascular responses were evaluated before and
5, 15, 30 and 60 minutes after injection of a catalase inhibitor (3-amino-1,2,4-triazole, 0.001 g/100 mL) into the
4th V.
RESULTS: Vehicle administration into the 4th V did not affect the cardiovascular response, whereas
administration of the central catalase inhibitor increased the basal HR and attenuated the bradycardic peak
(p,0.05) to a greater extent in WKY rats exposed to sidestream cigarette smoke than in WKY rats exposed to
fresh air. However, in spontaneously hypertensive rats, the effect of the catalase inhibitor treatment was
stronger in the fresh air condition (p,0.05).
CONCLUSION: Administration of a catalase inhibitor into the 4th V combined with exposure to sidestream
cigarette smoke has a stronger effect in WKY rats than in SH rats.
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& INTRODUCTION
The effects of cigarette smoke on the cardiovascular
system underlie the adverse effects of smoking on cardio-
vascular (1,2) and brain health, (3-5) in addition to
detrimental effects in different systems (6-8). Cigarette
smoke is classified into 2 categories: the mainstream smoke
usually inhaled by active smokers and the sidestream
smoke emitted from a cigarette and inhaled by so-called
‘‘passive smokers.’’ Sidestream cigarette smoke (SSCS) is
known to contain greater amounts of various oxidants and
other harmful compounds than mainstream smoke (9).
Thus, passive smokers are exposed to nearly the same
chemicals in cigarette smoke as active smokers, and passive
smoking has been found to increase the risk of cardiac or
other related diseases in nonsmokers (10).
Increased production of reactive oxygen species (ROS) by
cigarette smoke occurs as a direct effect of the radicals
present in smoke (11-13). For instance, it was previously
shown that cigarette exposure over 24 consecutive days
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increased mRNA levels of catalase in the heart by two fold
relative to only 1 day of exposure (14). ROS, such as
superoxide anions (O2
-) and hydrogen peroxide (H2O2),
were once thought only to be harmful byproducts of
oxidative metabolism but are now recognized as critical
second messengers in a wide range of cellular processes
(15). ROS are produced by the incomplete reduction of
oxygen to O2
-, which is spontaneously or enzymatically
dismutated to H2O2 by superoxide dismutase (SOD). H2O2
is transformed to H2O and O2 by the activity of catalase (16).
Previous investigations have associated brain ROS with
increased sympathetic activity (17,18), and systemic ROS
have also been associated with an impaired baroreflex (19).
Drugs injected into the fourth cerebral ventricle (4th V) may
easily reach structures surrounding the ventricular system
such as the area postrema (20). Previous studies have
indicated that ROS in the 4th V influence cardiovascular
responses (21). Moreover, administration of a catalase
inhibitor into the 4th V has also been demonstrated to
influence cardiovascular responses in normotensive rats
(22,23). Luchese et al. (24) indicated that acute cigarette
smoke exposure increases oxidative stress in the brain by
increasing the activity of reactive species and reducing the
activity of superoxide dismutase and catalase. Bartoli et al.
(25) suggested that increased baroreceptor reflex sensitivity
may compensate for particle-induced alterations in blood
pressure in dogs. In addition, our group previously
demonstrated that SSCS affects the cardiovascular
responses induced by central catalase inhibition in normo-
tensive rats (26). However, to the best of our knowledge, no
previous study has evaluated the effects of SSCS and central
catalase inhibition in spontaneously hypertensive (SH) rats.
Thus, to study the detailed mechanism of catalase inhibi-
tion, we investigated the effects of administration of a
catalase inhibitor into the 4th V on cardiovascular responses
in SH rats exposed to SSCS.
& METHODS
Animals
We used male Wistar Kyoto (WKY) rats and SH rats (16
weeks old) that were kept in the Animal Care Unit of our
university. The rats were housed individually in plastic
cages under standard laboratory conditions. The animals
were divided into 4 groups: WKY rats exposed to fresh air
(N = 7), WKY rats exposed to SSCS (N = 7), SH rats exposed
to fresh air (N = 7) and SH rats exposed to SSCS (N = 7). The
rats were kept under a 12-h light/dark cycle (lights on at
07:00 h) and had free access to food and water. The
institution’s Animal Ethics Committee authorized the
housing conditions and experimental procedures (number
0255/10). Efforts were made to minimize the number of
animals used.
SSCS exposure
The rats were placed in a transparent chamber with a
volume of approximately 95x80x65 cm3, with 4 rats per
chamber. The rats were maintained at 23¡1 C˚ and 50-60%
relative humidity. The carbon monoxide (CO) concentration
of the smoke in the chamber was maintained between 100-
300 ppm. Cigarettes were placed inside the chamber in a
small box, which prevented the rats from touching the
cigarettes. SSCS was produced by burning the cigarettes
inside the chamber without filtering. When the CO
concentration reached 100 ppm, the 180-minute interval
began. The cigarettes were replaced by new cigarettes to
maintain a CO concentration between 100-300 ppm. The rats
were exposed to SSCS for 180 minutes on 5 days per week,
and the total duration of the experiment was 3 weeks. All of
the exposures per performed in the morning, between 8 a.m.
and 12 p.m. The cigarettes used were of a commercial brand
with the following composition: 1.1 mg of nicotine, 14 mg of
tar and 15 mg of carbon monoxide. The control animals
were maintained in the same manner and same conditions
as the SSCS group but exposed to fresh air (27-29).
Surgical preparation
Five days before the experiment (one day after the last
SSCS exposure), the rats were anesthetized with ketamine
(50 mg/kg i.p.) and xylazine (50 mg/kg i.m.). After
anesthesia was applied to the scalp using 2% lidocaine,
the skull was exposed, and stainless steel guide cannulas (26
G) were implanted into the 4th V 1 mm above the site of
injection using a stereotaxic apparatus (Stoelting, USA). The
stereotactic coordinates for implantation of the cannula into
the 4th V were as follows: AP =213 mm from the bregma,
L = 0 mm from the medial suture and V =26 mm from the
skull. The cannulas were fixed to the skull using dental
cement and 1 metal screw (30).
One day before the experiment, the rats were anesthetized
with ketamine (50 mg/kg i.p.) and xylazine (50 mg/kg
i.m.), and a catheter was inserted into the abdominal aorta
through the femoral artery for monitoring of blood pressure
and heart rate. The catheters consisted of 4-cm segments of
PE-10 polyethylene tubing (Clay Adams, USA) that were
heat-bound to a 13-cm segment of PE-50 polyethylene
tubing. The catheters were tunneled under the skin and
exteriorized at the animal’s dorsum (31,32). After each
surgery, the animals received a single dose of an antibiotic
(ampicillin, 100 mg/kg) and a single dose of the analgesic
ketorolac (0.6 mg/kg).
Recording of arterial pressure and heart rate
After surgery, the animals were kept in the individual
cages used in their transport to the experiment room. The
animals were allowed 60 minutes to adapt to the conditions
of the experimental room, such as sound and illumination,
before the recording of the blood pressure and heart rate
was initiated. The experiment room was acoustically
isolated and had a constant background noise produced
by an air exhauster. At least another 30-minute period was
allowed before the experiments were initiated. The pulsatile
arterial pressure of the freely moving animals was recorded
using an HP-7754A preamplifier at a sampling frequency of
1,000 Hz (Hewlett Packard, USA) and an acquisition board
(MP100A, Biopac Systems Inc., USA) connected to a
computer. The mean arterial pressure (MAP) and heart rate
(HR) were derived from the pulsatile arterial pressure
recordings and processed on-line (33).
Baroreflex evaluation
The baroreflex was activated by intravenous phenylephr-
ine (PHE, 8 mg/kg, bolus) or sodium nitroprusside (SNP,
50 mg/kg, bolus). The baroreflex gain was calculated as the
derivation of HR in the function of the MAP variation
(DHR/DMAP, maximum changes in MAP and HR). The
sympathetic baroreflex gain (SBG) was defined as the DHR/
DMAP ratio in response to i.v. SNP, and parasympathetic
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baroreflex gain (PBG) was defined as the DHR/DMAP ratio
in response to i.v. PHE. We also analyzed the bradycardic
and tachycardic peak and HR range (i.e., the difference
between the bradycardic and tachycardic peaks) (34).
Injections into the 4th V
Injections into the 4th V were performed using 10-ml
Hamilton syringes connected by polyethylene tubing (PE-
10) to an injector needle. The injector, when completely
inserted, protruded 2 mm beyond the tip of the guide
cannula. The injections into the 4th V consisted of a volume
of 1.0 ml for approximately 5-10 s (35).
Protocol
Baroreflex and cardiovascular responses were evaluated
before (control) and 5, 15, 30 and 60 minutes after injection
of the catalase inhibitor (3-amino-1,2,4-triazole, ATZ,
0.001 g/100 mL) or vehicle (0.9% NaCl) into the 4th V of
conscious rats (23).
Histology
At the end of the experiments, the animals were
anesthetized using urethane (1.25 g/kg, i.p.), and 200 ml
of 1% Evan’s blue dye was injected in the 4th V as a marker
of the injection site. The chest was surgically opened, the
descending aorta occluded, the right atrium severed and the
brain perfused with 10% formalin through the left ventricle.
The brains were post-fixed for 24 h at 4 C˚, and 40-mm
sections were cut in a cryostat (model CM 1900, Leica,
Germany). The brain sections were stained with 1% neutral
red. The actual placement of the injection needle was
verified using serial sections (36).
Statistical analysis
The results were reported as the mean¡standard error of
the mean (SEM). Analyses of variance (ANOVA) for
repeated measures followed by the Tukey post-test were
applied to compare all variables (basal MAP and HR,
bradycardic and tachycardic peak, HR range, SBG, PBG,
PHE-induced increase and SNP-induced decrease in MAP
and bradycardic and tachycardic reflex). We compared the
variables at baseline (control) with the 5-, 15-, 30- and 60-
minute time points after injection of ATZ into the 4th V in
the same rat. We applied Student’s t-test to compare the
cardiovascular responses between WKY groups and SH
groups exposed to SSCS. Differences were considered
significant when the probability of a Type I error was less
than 5% (p,0.05).
& RESULTS
Effect of vehicle injection into the 4th V
Injection of vehicle (0.9% NaCl) into the 4th V did not
affect the basal MAP and HR, tachycardic and bradycardic
peak, HR range, SBG and PBG in WKY or SH rats exposed
to fresh air.
Effect of ATZ injection into the 4th V
Injection of ATZ into the 4th V did not affect the basal
MAP; however, the basal HR was increased at 30 minutes
(p,0.05) after ATZ administration in WKY rats exposed to
fresh air. Furthermore, the bradycardic peak was also
attenuated at 30 minutes. In contrast, we did not observe
significant changes in the bradycardic and tachycardic peak,
HR range, PBG and SBG after central catalase inhibition in
WKY rats exposed to fresh air (Table 1).
As shown in Table 4, injection of ATZ into the 4th V
produced a strong response in SH rats exposed to fresh air.
The basal HR increased was at 60 minutes and the
bradycardic peak was attenuated at 30 minutes after ATZ
administration. PBG was increased at 60 minutes after ATZ
treatment, whereas SBG was decreased at 30 and 60 minutes
(Table 2).
Among the groups exposed to SSCS, we observed stronger
effects for catalase inhibition in WKY rats. Central ATZ
Table 1 - Baseline mean arterial pressure (MAP) and heart rate (HR), bradycardic and tachycardic peak and sympathetic
(SBG) and parasympathetic baroreflex gain (PBG) in Wistar Kyoto rats exposed to fresh air and treated with ATZ
administered into the 4th V. N=7. Mean¡SEM. *p,0.05 for comparison with 09.
Variable 09 59 159 309 609
MAP (mmHg) 112¡13 116¡15 124¡16 127¡14 113¡14
HR (bpm) 315¡29 308¡24 318¡22 370¡22* 323¡25
Bradycardic Peak (bpm) 230¡28 260¡20 263¡29 318¡22* 252¡21
Tachycardic Peak (bpm) 417¡25 419¡23 454¡28 469¡31 425¡36
HR range (bpm) 187¡19 166¡11 191¡16 151¡18 173¡17
PBG (bpm x mmHg-1) -1.73¡0.24 -1.54¡0.03 -1.56¡0.14 -1.9¡0.6 -1.35¡0.04
SBG (bpm x mmHg-1) -2.25¡0.23 -2.24¡0.43 -1.93¡0.16 -2.64¡0.45 -2.5¡0.26
Table 2 - Baseline mean arterial pressure (MAP) and heart rate (HR), bradycardic and tachycardic peak and sympathetic
(SBG) and parasympathetic baroreflex gain (PBG) in SH rats exposed to fresh air and treated with ATZ administered into
the 4th V. N=7. Mean¡SEM. *p,0.05 for comparison with 09.
Variable 09 59 159 309 609
MAP (mmHg) 176¡16 192¡14 180¡11 175¡15 175¡16
HR (bpm) 322¡22 407¡22* 340¡21* 343¡27* 341¡29*
Bradycardic Peak (bpm) 273¡19 352¡19* 305¡21* 308¡28* 309¡28
Tachycardic Peak (bpm) 442¡37 463¡31 445¡31 455¡34 445¡32
HR range (bpm) 154¡17 111¡12 142¡11 147¡11 148¡12
PBG (bpm x mmHg-1) -0.35¡0.03 -1.2¡0.14* -0.8¡0.05* -0.67¡0.13* -0.7¡0.12*
SBG (bpm x mmHg-1) -2¡0.18 -1.96¡0.01 -2.16¡0.08 -1.39¡0.13* -1.36¡0.1*
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administration increased the basal HR at 5, 15 and 30 minutes
and reduced the bradycardic peak at 15 and 30 minutes
(Table 3).
In the SH rats exposed to SSCS, we observed that ATZ
treatment increased the basal HR during the first 30
minutes, reduced the bradycardic peak at 5 and 15 minutes
and reduced the tachycardic peak at 60 minutes (Table 4).
Comparison of cardiovascular responses between
WKY rats and SH rats exposed to SSCS and treated
with ATZ
In Table 5, we present a comparison of the cardiovascular
responses induced by central ATZ administration between
the WKY and SH rats exposed to SSCS at each time point. It
should be noted that almost all variables were different
between the groups before ATZ injection. However, the
differences were not significant after the injection of ATZ.
& DISCUSSION
This study was undertaken to evaluate the effects of
central catalase inhibitor administration on cardiovascular
responses in WKY and SH rats exposed to SSCS. We
observed that administration of a catalase inhibitor into the
4th V produced a strong effect on cardiovascular responses
in WKY rats exposed to SSCS but not in SH rats exposed to
SSCS. The lack of any change in the vehicle-treated group is
consistent with these findings.
Based on our data, injection of ATZ into the 4th V did not
affect the sympathetic and parasympathetic baroreflex gain
in WKY rats. A previous study published by our group (22)
reported that central ATZ administration into the 4th V did
not affect the same components of the baroreflex in Wistar
rats. We also reported that central catalase inhibition
increased the parasympathetic baroreflex gain and reduced
the sympathetic baroreflex gain in SH rats. The present
study provides additional information because a different
response was observed in the SH group. We therefore
consider that central catalase inhibition affects the para-
sympathetic and sympathetic baroreflex gain to a greater
extent in SH rats than in WKY rats. This hypothesis is
supported by our previous study that investigated the
cardiopulmonary reflex responses to catalase inhibitor
administration into the 4th V in SH and WKY rats (37).
In the present study, administration of a catalase inhibitor
into the 4th V strongly attenuated the bradycardic peak in
WKY rats exposed to SSCS, whereas this response was not
enhanced in SH rats exposed to SSCS. The parasympathetic
activity of the baroreflex response is represented by the
bradycardic peak, whereas the sympathetic activity during
the baroreflex is represented by the tachycardic peak, and
the difference between both peaks corresponds to the HR
range (38). Our findings indicate that SSCS exposure has a
stronger effect on parasympathetic activity in WKY rats
than in SH rats. A recent study demonstrated that vagal
modulation of the heart is blunted in heavy smokers,
particularly during parasympathetic modulation (39).
Considering that SH rats present increased levels of ROS
in the brain relative to normotensive rats (40,41), we
hypothesize that 3 weeks of exposure to SSCS was not
sufficient to increase ROS production in the 4th V and affect
cardiovascular responses.
We observed that acute administration of the catalase
inhibitor into the 4th V had a strong effect on the
parasympathetic regulation of the cardiovascular system
in WKY rats exposed to SSCS because it strongly increased
the basal HR. Conversely, in SH rats, the central catalase
inhibitor treatment strongly affected cardiovascular
responses in the group exposed to fresh air. In particular,
administration of the catalase inhibitor into the 4th V
increased the parasympathetic baroreflex gain and reduced
the sympathetic baroreflex gain in the group exposed to
fresh air, whereas it did not affect these components in SH
rats exposed to SSCS. As mentioned above, we believe that 3
weeks of exposure to SSCS is insufficient to induce changes
in ROS in the 4th V of the SH rats, possibly because the SH
Table 3 - Baseline mean arterial pressure (MAP) and heart rate (HR), bradycardic and tachycardic peak and sympathetic
(SBG) and parasympathetic baroreflex gain (PBG) in Wistar Kyoto rats exposed to SSCS and treated with ATZ
administered into the 4th V. N=7. Mean¡SEM. *p,0.05 for comparison with 09.
Variable 09 59 159 309 609
MAP (mmHg) 106¡13 118¡14 111¡15 107¡12 107¡13
HR (bpm) 344¡16 412¡19* 440¡13* 429¡17* 397¡13
Bradycardic Peak (bpm) 279¡14 323¡19 364¡26* 380¡18* 318¡10
Tachycardic Peak (bpm) 489¡11 506¡18 525¡19 527¡14 502¡12
HR range (bpm) 203¡12 183¡13 161¡22 169¡25 183¡11
PBG (bpm x mmHg-1) -1.2¡0.34 -1.19¡0.11 -1.08¡0.22 -0.85¡0.13 -1.11¡0.19
SBG (bpm x mmHg-1) -1.48¡0.2 -1.26¡0.14 -1.39¡0.26 -1.13¡0.1 -1.84¡0.21
Table 4 - Baseline mean arterial pressure (MAP) and heart rate (HR), bradycardic and tachycardic peak and sympathetic
(SBG) and parasympathetic baroreflex gain (PBG) in SH rats exposed to SSCS and treated with ATZ administration into
the 4th V. N=7. Mean¡SEM. *p,0.05 for comparison with 09.
Variable 09 59 159 309 609
MAP (mmHg) 168¡13 175¡15 176¡13 173¡12 170¡11
HR (bpm) 317¡21 429¡22* 398¡24* 380¡24* 344¡28
Bradycardic Peak (bpm) 213¡17 307¡32* 298¡14* 270¡17 26¡18
Tachycardic Peak (bpm) 504¡28 522¡28 519¡27 519¡29 475¡25*
HR range (bpm) 272¡11 216¡29 222¡11 249¡15 213¡11
PBG (bpm x mmHg-1) -1.9¡0.23 -2.87¡0.5 -2.77¡0.9 -2.4¡0.52 -1.65¡0.19
SBG (bpm x mmHg-1) -3.16¡0.3 -2.46¡0.45 -3.03¡0.59 -2.73¡0.31 -3.31¡0.43
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rats present higher basal levels of ROS in the brain (40,41).
Thus, a stronger stimulus may be necessary to induce
changes in ROS in the brain of SH rats.
A recent study published by our group demonstrated that
central catalase inhibition increased the basal HR and
attenuated the bradycardic peak in Wistar rats exposed to
SSCS (26). In our current investigation, WKY rats exposed to
SSCS presented similar responses, which thus supports the
results of our previous study (26). In this case, we aimed to
determine whether SH rats exposed to SSCS would present
increased responses. However, SH rats exposed to fresh air
presented greater responses than SH rats exposed to SSCS.
In this context, we also found in this study that before
injection of the catalase inhibitor into the 4th V, a difference
existed between the WKY and SH groups exposed to SSCS
regarding basal MAP and HR, bradycardic peak, HR range
and sympathetic and parasympathetic baroreflex gain. This
finding is in agreement with our previous studies (34).
However, after central administration of the catalase
inhibitor, these variables were no longer significantly
different between the groups. Therefore administration of
the catalase inhibitor into the 4th V combined with exposure
to SSCS likely had a greater acute effect in WKY rats than
SH rats.
Based on our findings, we suggest that SSCS exposure
affects the oxidative stress balance in the 4th V in WKY rats.
The morphology of the nose can be affected by substances
able to achieve passage into the brain, and some substances
may enter the brain through cranial nerves (42). We believe
that the olfactory vector hypothesis for neurological
diseases may explain our data (43). Prior studies have
indicated that substances injected into the 4th V preferably
reach the parasympathetic system. Areas such as the dorsal
motor nucleus of the vagus and nucleus ambiguus receive
glutamatergic projections from the nucleus of the solitary
tract (20).
We used SSCS exposure in this investigation because it
has been suggested that SSCS is more toxic than mainstream
cigarette smoke (44). Indeed, the Philip Morris Company
secretly performed in vivo toxicological tests of the effects of
sidestream smoke (44) and observed that condensates and
sidestream particulate matter present more mutagenic
effects than the mainstream particulate matter. Moreover,
SSCS contains approximately 200-fold more ammonia than
mainstream smoke. SSCS presents a higher density of toxic
substances than mainstream smoke because of its lower
temperature of combustion and absence of filtering (45). For
example, SSCS has five-fold more acrolein than mainstream
smoke (46). On inhalation, fresh sidestream smoke is two- to
six-fold more toxic per gram than mainstream smoke,
depending on the end point (47). Taken together, our
results and the findings of these other studies are relevant
for directing and implementing public health policies.
In our research, the baroreflex was investigated in
conscious, unanesthetized rats because anesthesia affects
cardiovascular responses (48). We believe that our investi-
gation provides reliable information regarding the effects of
the administration of the catalase inhibitor ATZ into the 4th
V on cardiovascular responses in conscious rats. Our results
are useful because recently, the cardiovascular reflex has
been studied in different rat models and strains (49-51) with
the aim of preventing the development of cardiovascular
disorders in humans (52-54), as reduced cardiovascular
reflex responses are indicative of cardiovascular disease (55-
57). However, some points must be considered. We did not
quantify concentrations of H2O2 or other ROS in the 4
th V
during the procedures. Such data would reinforce our
results by demonstrating that the ROS levels are changed in
the 4th V. A previous study (58) reported a technique for
continuous on-line measurement of cerebral H2O2.
In conclusion, our findings indicate that administration of
a catalase inhibitor into the 4th V has strong effects on WKY
rats but not SH rats exposed to SSCS.
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